Better Choice Q2 net revenue $10.5M; gross margin up 543 bps YoY to 34%

SRx Health Solutions, Inc.

2023-Q2 EPS reported -$0.21 revenue$19,773,000

Net revenue of $10.5M, down 36% YoY but up 14% from Q1 2023.
Gross margin improved 543 bps YoY to 34%; operating loss improved 39% to $(2.6)M.
Net loss improved 32% to $(3.0)M; EPS improved 33% YoY to $(0.10).
Appointed Kent Cunningham as CEO; strategic partnership with Alphia for dry kibble manufacturing.
Paid down $13.5M revolving credit line; supply chain constraints expected to resolve by end of Q3.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SRx Health Solutions, Inc. reported second quarter ended June 30, 2023 results: revenue $10.5 million, net income $(3.0) million, EPS $(0.10).

Period: second quarter ended June 30, 2023
Revenue: $10.5 million
Net income: $(3.0) million
EPS: $(0.10)
Result: reported results

Exact text from the filing

Net revenue increased 14% from first quarter 2023 to $10.5 million

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

SRx Health Solutions, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-030190

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.